Philipp J. Jost

15.2k total citations · 1 hit paper
108 papers, 4.5k citations indexed

About

Philipp J. Jost is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Philipp J. Jost has authored 108 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Philipp J. Jost's work include Cancer Genomics and Diagnostics (18 papers), Cell death mechanisms and regulation (18 papers) and Acute Myeloid Leukemia Research (10 papers). Philipp J. Jost is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Cell death mechanisms and regulation (18 papers) and Acute Myeloid Leukemia Research (10 papers). Philipp J. Jost collaborates with scholars based in Germany, Austria and United States. Philipp J. Jost's co-authors include Andreas Strasser, Shigekazu Nagata, Jürgen Ruland, Thomas Kaufmann, John Silke, Monica Yabal, Philippe Bouillet, Rune Busk Damgaard, Christian Peschel and Mads Gyrd‐Hansen and has published in prestigious journals such as Nature, Science and Journal of Clinical Oncology.

In The Last Decade

Philipp J. Jost

101 papers receiving 4.5k citations

Hit Papers

The Many Roles of FAS Rec... 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Many Roles of FAS Receptor Signaling in the Immune System
    2009 723 citations Andreas Strasser, Philipp J. Jost et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Philipp J. Jost 2.5k 1.6k 863 808 507 108 4.5k
Kohsuke Imai 3.3k 1.3× 2.4k 1.5× 1.0k 1.2× 760 0.9× 781 1.5× 232 6.6k
Johannes Stöckl 2.0k 0.8× 2.9k 1.8× 1.5k 1.7× 496 0.6× 521 1.0× 93 5.9k
Cornelis L. Verweij 2.4k 0.9× 2.0k 1.2× 1.4k 1.6× 464 0.6× 449 0.9× 62 6.1k
Said Dermime 1.9k 0.7× 2.2k 1.3× 2.6k 3.0× 596 0.7× 433 0.9× 101 5.6k
Martina Müller 3.1k 1.2× 1.0k 0.6× 1.7k 2.0× 818 1.0× 885 1.7× 140 5.9k
Laura DeForge 3.2k 1.3× 2.5k 1.5× 1.1k 1.3× 789 1.0× 877 1.7× 54 5.8k
Maciej M. Markiewski 1.3k 0.5× 2.6k 1.6× 801 0.9× 381 0.5× 751 1.5× 69 4.9k
Ping Chen 2.2k 0.9× 906 0.5× 828 1.0× 931 1.2× 597 1.2× 189 4.7k
Seiichi Kitagawa 1.4k 0.6× 1.9k 1.2× 911 1.1× 469 0.6× 360 0.7× 128 4.1k
Alice Mui 2.6k 1.0× 3.0k 1.8× 2.6k 3.0× 747 0.9× 424 0.8× 92 6.5k

Countries citing papers authored by Philipp J. Jost

Since Specialization
Citations

This map shows the geographic impact of Philipp J. Jost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp J. Jost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp J. Jost more than expected).

Fields of papers citing papers by Philipp J. Jost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp J. Jost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp J. Jost. The network helps show where Philipp J. Jost may publish in the future.

Co-authorship network of co-authors of Philipp J. Jost

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp J. Jost. A scholar is included among the top collaborators of Philipp J. Jost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp J. Jost. Philipp J. Jost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Anne C., Noemı́ Reguart, Philipp J. Jost, et al.. (2024). 155P Tarlatamab for patients with small cell lung cancer: 6-8 hour outpatient vs 48 hour inpatient monitoring in cycle 1. Immuno-Oncology Technology. 24. 100784–100784. 1 indexed citations
2.
3.
Dowlati, Afshin, Horst-Dieter Hummel, Stéphane Champiat, et al.. (2024). Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of Clinical Oncology. 42(29). 3392–3399. 22 indexed citations
4.
Schranz, Anna, Faisal Aziz, Doris Wagner, et al.. (2023). Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases—A Retrospective Analysis. Journal of Clinical Medicine. 12(24). 7532–7532. 1 indexed citations
5.
Jost, Philipp J., et al.. (2023). Epigallocatechin gallate inhibits Francisella tularensis growth and suppresses the function of DNA-binding protein HU. Microbial Pathogenesis. 176. 105999–105999. 3 indexed citations
6.
Joensuu, Heikki, Eva Wardelmann, Mikael Eriksson, et al.. (2023). KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial. Clinical Cancer Research. 29(17). 3313–3319. 13 indexed citations
7.
Rassner, Michael, Marie Follo, Stefanie Jilg, et al.. (2023). Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST). International Journal of Molecular Sciences. 24(6). 5411–5411. 1 indexed citations
8.
Munkhbaatar, Enkhtsetseg, Ulrike Höckendorf, Michelle Dietzen, et al.. (2022). The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner. Oncogene. 41(9). 1376–1382. 10 indexed citations
9.
Wahida, Adam, Lars Buschhorn, Stefan Fröhling, et al.. (2022). The coming decade in precision oncology: six riddles. Nature reviews. Cancer. 23(1). 43–54. 121 indexed citations
10.
Lange, Sebastian, H. Carlo Maurer, Kenneth P. Olive, et al.. (2021). PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer. JCI Insight. 6(8). 7 indexed citations
11.
12.
Suppan, Christoph, Florian Posch, Daniel Steiner, et al.. (2021). Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity. Cancers. 13(10). 2492–2492. 10 indexed citations
13.
Spilgies, Lisanne M., Monica Yabal, Erika Owsley, et al.. (2019). TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Cell Death and Disease. 10(10). 56–56. 28 indexed citations
14.
Jost, Philipp J., et al.. (2017). Gene therapy for X-linked Inhibitor of Apoptosis Protein (XIAP) deficiency. Human Gene Therapy. 28. 1 indexed citations
15.
Fernández‐Marrero, Yuniel, et al.. (2016). Survival control of malignant lymphocytes by anti-apoptotic MCL-1. Leukemia. 30(11). 2152–2159. 31 indexed citations
16.
Wong, W. Wei‐Lynn, et al.. (2016). Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils. Cell Death and Disease. 7(10). e2422–e2422. 70 indexed citations
17.
Vávrová, Jiřina, Philipp J. Jost, Aleš Tichý, et al.. (2016). Comparison of the Radiosensitizing Effect of ATR, ATM and DNA-PK Kinase Inhibitors on Cervical Carcinoma Cells. Folia Biologica. 62(4). 167–174. 8 indexed citations
18.
Wong, W. Wei‐Lynn, James E. Vince, Najoua Lalaoui, et al.. (2014). cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood. 123(16). 2562–2572. 128 indexed citations
19.
Maier, Jacqueline, Thoralf Lange, Irina Kerle, et al.. (2013). Detection of Mutant Free Circulating Tumor DNA in the Plasma of Patients with Gastrointestinal Stromal Tumor Harboring Activating Mutations of CKIT or PDGFRA. Clinical Cancer Research. 19(17). 4854–4867. 60 indexed citations
20.
Vikstrom, Ingela B., Sebastian Carotta, Katja Lüthje, et al.. (2010). Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory. Science. 330(6007). 1095–1099. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kohsuke Imai Breakdown of academic impact, for papers by Johannes Stöckl Breakdown of academic impact, for papers by Cornelis L. Verweij Breakdown of academic impact, for papers by Said Dermime Breakdown of academic impact, for papers by Martina Müller Breakdown of academic impact, for papers by Laura DeForge Breakdown of academic impact, for papers by Maciej M. Markiewski Breakdown of academic impact, for papers by Ping Chen Breakdown of academic impact, for papers by Seiichi Kitagawa Breakdown of academic impact, for papers by Alice Mui
Rankless by CCL
2026